Viewing Study NCT05318469


Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2026-02-22 @ 6:46 PM
Study NCT ID: NCT05318469
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2022-04-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer
Sponsor: Yuan Yuan
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anatomic Stage IV Breast Cancer AJCC v8 View
None Metastatic Triple-Negative Breast Carcinoma View
Keywords: